loading

Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten

pulisher
Jun 03, 2025

Ameriprise Financial Inc. Purchases 40,700 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Buys 45,518 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Nuveen Asset Management LLC Has $3.54 Million Stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

What is HC Wainwright’s Forecast for OCUL Q1 Earnings? - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Ocular gains as Wet AMD trial for lead asset reaches enrollment target - MSN

Jun 01, 2025
pulisher
May 30, 2025

Ocular Therapeutix (NASDAQ:OCUL) Given Buy Rating at HC Wainwright - Defense World

May 30, 2025
pulisher
May 30, 2025

Ocular Therapeutix (OCUL) Maintains "Buy" Rating with $15 Price Target | OCUL Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Takes $3.82 Million Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 30, 2025
pulisher
May 30, 2025

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock Holdings Lessened by Bank of America Corp DE - Defense World

May 30, 2025
pulisher
May 29, 2025

Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews - Benzinga

May 29, 2025
pulisher
May 29, 2025

Ocular Therapeutix (OCUL) Advances with Axpaxli Trial Completion - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Ocular Therapeutix (NASDAQ:OCUL) Has Debt But No Earnings; Should You Worry? - simplywall.st

May 29, 2025
pulisher
May 28, 2025

Sector Update: Health Care - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Ocular Shares Rise After Eye Disease Trial Nears Enrollment Completion - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Ocular stock gains after wet AMD trial update (OCUL:NASDAQ) - Seeking Alpha

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix chief scientific officer sells $21,712 in stock - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix (OCUL) Concludes Enrollment for Key Retinal Trial | OCUL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix™ To Close Enrollment This Week for - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration | OCUL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Ocular Therapeutix chief scientific officer sells $21,712 in stock By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $755,000 Stock Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 28, 2025
pulisher
May 28, 2025

D. E. Shaw & Co. Inc. Takes $268,000 Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 28, 2025
pulisher
May 27, 2025

Ocular Therapeutix Executives Sell Shares to Cover Tax Obligations - TradingView

May 27, 2025
pulisher
May 27, 2025

Ocular Therapeutix at Stifel 2025 Forum: Eyeing a Disruptive Future By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

(OCUL) Trading Report - news.stocktradersdaily.com

May 27, 2025
pulisher
May 24, 2025

BNP Paribas Financial Markets Acquires 39,599 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 24, 2025
pulisher
May 21, 2025

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Ocular Therapeutix at BioConnect: Strategic Advances in Wet AMD Treatment By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 17, 2025

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Holdings Boosted by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 14, 2025

Ocular Therapeutix™ to Participate in Upcoming Investor Conferences - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Ocular Therapeutix CEO to Present at RBC, Mizuho, and Top Healthcare Conferences: Key Dates for Investors - Stock Titan

May 14, 2025
pulisher
May 14, 2025

The Manufacturers Life Insurance Company Sells 2,399 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 14, 2025
pulisher
May 13, 2025

Transcript : Ocular Therapeutix, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 09 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Hsbc Holdings PLC Buys 5,853 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 12, 2025
pulisher
May 11, 2025

Tower Research Capital LLC TRC Has $76,000 Stock Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 11, 2025
pulisher
May 09, 2025

HC Wainwright Analysts Reduce Earnings Estimates for OCUL - Defense World

May 09, 2025
pulisher
May 09, 2025

William Blair Brokers Decrease Earnings Estimates for OCUL - Defense World

May 09, 2025
pulisher
May 08, 2025

Analysts Offer Predictions for OCUL FY2026 Earnings - Defense World

May 08, 2025
pulisher
May 07, 2025

Ocular Therapeutix at The Citizens JMP Life Sciences Conference: Strategic Insights - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Bearish: Analysts Just Cut Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) Revenue and EPS estimates - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Analysts Just Slashed Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) EPS Numbers - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Ocular Therapeutix (NASDAQ:OCUL) Trading Down 6.5% on Analyst Downgrade - Defense World

May 07, 2025
pulisher
May 06, 2025

Analyst Expectations For Ocular Therapeutix's Future - Benzinga

May 06, 2025
pulisher
May 06, 2025

Ocular Therapeutix (OCUL) Maintained as Buy by Needham, Price Ta - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ocular Therapeutix First Quarter 2025 Earnings: Misses Expectations - Yahoo

May 06, 2025
pulisher
May 06, 2025

Ocular Therapeutix Advances in Retinal Treatment Trials - TipRanks

May 06, 2025
pulisher
May 06, 2025

Decoding Ocular Therapeutix Inc (OCUL): A Strategic SWOT Insight - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Ocular Therapeutix: Q1 Earnings Snapshot - MySA

May 05, 2025
pulisher
May 05, 2025

Ocular Therapeutix sees cash runway into 2028 - TipRanks

May 05, 2025
pulisher
May 05, 2025

Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings - Benzinga

May 05, 2025
pulisher
May 05, 2025

Ocular Therapeutix reports Q1 EPS (38c), consensus (28c) - TipRanks

May 05, 2025
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):